Establishment of an Experimental System for Intraperitoneal Chemotherapy in a Rat Model
Open Access
- 17 August 2021
- journal article
- research article
- Published by International Institute of Anticancer Research in In Vivo
- Vol. 35 (5) , 2703-2710
Abstract
Aim: To establish an experimental system for comparing different methods of intraperitoneal chemotherapy in a rat model. Materials and Methods: We used six-week-old Sprague–Dawley rats, and created an early postoperative intraperitoneal chemotherapy (EPIC) system using 18-gauge syringes and evacuators, and a hyperthermic intraperitoneal chemotherapy (HIPEC) system using two peristaltic pumps which controlled the flow rate and temperature. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) was achieved using a nozzle for dispersing aerosols at a flow rate up to 41.5 ml/min. The distribution and intensity of 0.2% trypan blue dye was compared among three methods. Results: The distribution was limited and the intensity was weak after EPIC, and the dye stained moderately in gravity-dependent regions after HIPEC. On the other hand, the distribution was the most comprehensive, and the intensity was the greatest after PIPAC. Conclusion: This experimental system in a rat model may reflect the comparative effect among EPIC, HIPEC and PIPAC in humans.Keywords
This publication has 45 references indexed in Scilit:
- Renal and Hepatic Toxicities After Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC)Annals of Surgical Oncology, 2013
- Therapeutic approach of human peritoneal carcinomatosis with Dbait in combination with capnoperitoneum: proof of conceptSurgical Endoscopy, 2011
- Comparison of hyperthermia and adrenaline to enhance the intratumoral accumulation of cisplatin in a murin model of peritoneal carcinomatosisJournal of Experimental & Clinical Cancer Research, 2011
- Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery for peritoneal carcinomatosis in an experimental modelBritish Journal of Surgery, 2010
- In vivo Toxicity and Bioavailability of Taxol® and a Paclitaxel/β-Cyclodextrin Formulation in a Rat Model During HIPECAnnals of Surgical Oncology, 2010
- The Effects of Adjuvant Experimental Radioimmunotherapy and Hyperthermic Intraperitoneal Chemotherapy on Intestinal and Abdominal Healing after Cytoreductive Surgery for Peritoneal Carcinomatosis in the RatAnnals of Surgical Oncology, 2008
- A Comparison Between Radioimmunotherapy and Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Peritoneal Carcinomatosis of Colonic Origin in RatsAnnals of Surgical Oncology, 2007
- Short-Term Exposure of Cancer Cells to Micromolar Doses of Paclitaxel, with or without Hyperthermia, Induces Long-Term Inhibition of Cell Proliferation and Cell Death In VitroAnnals of Surgical Oncology, 2007
- Peritoneal carcinomatosis from colorectal cancerBritish Journal of Surgery, 2002
- Combined intraperitoneal plus intravenous chemotherapy after curative resection for colonic adenocarcinomaEuropean Journal of Cancer, 1995